P

Assignee

ALKERMES INC

US155 patents

Top patents by PatentIndex Score

US6194006B1Feb 27, 2001

Preparation of microparticles having a selected release profile

ALKERMES INC115 citations99
US6110503AAug 29, 2000

Preparation of biodegradable, biocompatible microparticles containing a biologically active agent

ALKERMES INC129 citations99
US5916598AJun 29, 1999

Preparation of biodegradable, biocompatible microparticles containing a biologically active agent

ALKERMES INC138 citations99
US5912015AJun 15, 1999

Modulated release from biocompatible polymers

ALKERMES INC557 citations99
US5792477AAug 11, 1998

Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent

ALKERMES INC247 citations99
US5733566AMar 31, 1998

Controlled release of antiparasitic agents in animals

ALKERMES INC1,587 citations99
US5656297AAug 12, 1997

Modulated release from biocompatible polymers

ALKERMES INC404 citations99
US5413797AMay 9, 1995

Controlled release ACTH containing microspheres

ALKERMES INC330 citations99
US5112596AMay 12, 1992

Method for increasing blood-brain barrier permeability by administering a bradykinin agonist of blood-brain barrier permeability

ALKERMES INC293 citations99
US7556798B2Jul 7, 2009

Highly efficient delivery of a large therapeutic mass aerosol

ALKERMES INC113 citations98
US6749866B2Jun 15, 2004

Modulated release from biocompatible polymers

ALKERMES INC76 citations98
US6596316B2Jul 22, 2003

Preparation of microparticles having a selected release profile

ALKERMES INC89 citations98
US6555525B2Apr 29, 2003

Microencapsulation and sustained release of oligonucleotides

ALKERMES INC211 citations98
US6544559B2Apr 8, 2003

Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles

ALKERMES INC76 citations98
US6495164B1Dec 17, 2002

Preparation of injectable suspensions having improved injectability

ALKERMES INC246 citations98
US6265389B1Jul 24, 2001

Microencapsulation and sustained release of oligonucleotides

ALKERMES INC230 citations98
US6264987B1Jul 24, 2001

Method for preparing microparticles having a selected polymer molecular weight

ALKERMES INC92 citations98
US6015555AJan 18, 2000

Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates

ALKERMES INC235 citations98
US5965168AOct 12, 1999

Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles

ALKERMES INC128 citations98
US5922253AJul 13, 1999

Production scale method of forming microparticles

ALKERMES INC186 citations98
US5916597AJun 29, 1999

Composition and method using solid-phase particles for sustained in vivo release of a biologically active agent

ALKERMES INC601 citations98
US5833988ANov 10, 1998

Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates

ALKERMES INC198 citations98
US5817343AOct 6, 1998

Method for fabricating polymer-based controlled-release devices

ALKERMES INC245 citations98
US5770231AJun 23, 1998

Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles 1,2-benzisothiazoles

ALKERMES INC182 citations98
US5686416ANov 11, 1997

Increasing blood-brain barrier permeability with permeabilizer peptides

ALKERMES INC252 citations98
US5667808ASep 16, 1997

Composition for sustained release of human growth hormone

ALKERMES INC194 citations98
US5654010AAug 5, 1997

Composition for sustained release of human growth hormone

ALKERMES INC353 citations98
US5527527AJun 18, 1996

Transferrin receptor specific antibody-neuropharmaceutical agent conjugates

ALKERMES INC273 citations98
US5506206AApr 9, 1996

Increasing blood-brain barrier permeability with permeabilizer peptides

ALKERMES INC481 citations98
US5268164ADec 7, 1993

Increasing blood-brain barrier permeability with permeabilizer peptides

ALKERMES INC539 citations98
US5182107AJan 26, 1993

Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates

ALKERMES INC221 citations98
US7612176B2Nov 3, 2009

Polymer-based sustained release device

ALKERMES INC69 citations97
US6667061B2Dec 23, 2003

Preparation of injectable suspensions having improved injectability

ALKERMES INC89 citations97
US6465425B1Oct 15, 2002

Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins

ALKERMES INC98 citations97
US6329508B1Dec 11, 2001

Transferrin receptor reactive chimeric antibodies

ALKERMES INC130 citations97
US6183781B1Feb 6, 2001

Method for fabricating polymer-based controlled-release devices

ALKERMES INC94 citations97
US5989463ANov 23, 1999

Methods for fabricating polymer-based controlled release devices

ALKERMES INC684 citations97
US5716644AFeb 10, 1998

Composition for sustained release of non-aggregated erythropoietin

ALKERMES INC244 citations97
US5674534AOct 7, 1997

Composition for sustained release of non-aggregated erythropoietin

ALKERMES INC238 citations97
US5654008AAug 5, 1997

Preparation of biodegradable microparticles containing a biologically active agent

ALKERMES INC339 citations97
US5271961ADec 21, 1993

Method for producing protein microspheres

ALKERMES INC651 citations97
US7879358B2Feb 1, 2011

Pulmonary delivery for levodopa

ALKERMES INC46 citations96
US7563871B2Jul 21, 2009

Polymer-based sustained release device

ALKERMES INC79 citations96
US7456254B2Nov 25, 2008

Polymer-based sustained release device

ALKERMES INC95 citations96
US7223440B2May 29, 2007

Residual solvent extraction method and microparticles produced thereby

ALKERMES INC35 citations96
US6824822B2Nov 30, 2004

Residual solvent extraction method and microparticles produced thereby

ALKERMES INC63 citations96
US6569458B1May 27, 2003

Process for producing small particles of biologically active molecules

ALKERMES INC130 citations96
US6565888B1May 20, 2003

Methods and compositions for the targeted delivery of biologically active agents

ALKERMES INC57 citations96
US6540393B1Apr 1, 2003

Apparatus for preparing microparticles using in-line solvent extraction

ALKERMES INC41 citations96
US6534092B2Mar 18, 2003

Method for preparing microparticles having a selected polymer molecular weight

ALKERMES INC54 citations96

Showing the top 50 of 155 patents by PatentIndex Score.